NSRGF Stock Recent News

Transaction ensures Nestlé Health Science will continue to commercialize the product BRIDGEWATER, N.J. , June 6, 2024 /PRNewswire/ -- Seres Therapeutics, Inc. (Nasdaq: MCRB), announced today that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST (fecal microbiota spores, live-brpk) capsules.

Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years.

Nestlé is launching a frozen food brand specifically aimed at people taking GLP-1 diabetes and weight loss drugs like Ozempic and Wegovy, the company announced Tuesday, part of the food giant's wider strategy to offset potential sales losses as appetite-suppressing drugs grow popular.

The firm said it expects organic sales growth of around 4% in 2024, and a "moderate increase" in its underlying trading operating profit margin.

Britain's Competition and Markets Authority (CMA) has opened a new phase of its investigation into the market for baby formula in the UK. Having found that the price of baby formula had climbed by 25% over the past two years last November, the CMA said a market study would now begin, allowing the regulator to use its compulsory information-gathering powers.

Love is in the air – at least, for certain picks on the stock market it is. America's National Retail Federation says that nearly $26 billion will be spent on Valentines Day this year in the U.S. alone, representing “a new high of $14.

Coca Cola HBC AG (LSE:CCH), Nestle S.A. (OTC:NSRGF, VTX:NESN) and Danone (OTCQX:DANOY) have been accused of making “misleading” claims about the recyclability of plastic bottles.